Enhanced coronary flow velocity during intra-aortic balloon pumping assessed by transthoracic doppler echocardiography  by Takeuchi, Masaaki et al.
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OBJECTIVES The study was done to determine potential utility of measuring coronary flow velocity (CFV)
by transthoracic Doppler echocardiography (TTDE) during intra-aortic balloon pumping
(IABP).
BACKGROUND Use of IABP has been shown to increase CFV assessed by an invasive technique. The CFV
in the left anterior descending coronary artery (LAD) can be measured by TTDE.
METHODS Coronary flow velocity in the distal LAD by TTDE was measured in 40 critically ill patients
requiring IABP. All patients received emergency coronary angiography. Both CFV and
pressure data were obtained during 1:2 balloon pumping.
RESULTS Adequate diastolic CFV recording was obtained in all patients. The IABP decreased systolic
pressure and increased diastolic pressure. Average peak diastolic flow velocity and diastolic
velocity time integral was 19  11 cm/s and 7.7  4.4 cm with non-augmented beat. These
values were increased significantly (61  38%, 59  35%, p  0.001) with augmented beat.
Significant correlation was noted between % diastolic pressure augmentation and % increase
in diastolic CFV (r  0.62 to 0.69, p  0.001). There was no significant difference in flow
enhancement during IABP, irrespective to the proximal LAD stenosis severity (severe
stenosis: 73  70%; intermediate stenosis: 61  29%; no significant stenosis: 58  29%; p
 NS, analysis of variance). By continuous recording of CFV, the optimal timing of balloon
control could be adjusted to maximize flow velocity during augmentation.
CONCLUSIONS Use of TTDE can be employed in monitoring CFV augmentation during IABP. The IABP
produced significant distal flow enhancement even in patients with critical proximal stenosis.
This totally noninvasive approach may help to optimize the benefits of IABP for coronary
flow augmentation. (J Am Coll Cardiol 2004;43:368–76) © 2004 by the American College
of Cardiology Foundations
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plthough intra-aortic balloon pumping (IABP) has benefi-
ial effect on cardiac afterload, controversy exists about its
bility to increase coronary blood flow in patients with
eperfused acute myocardial infarction (MI) or in those who
ave significant coronary stenosis (1–6). Previous studies
sing Doppler-tipped angioplasty guide wire demonstrated
ack of significant flow improvement beyond most critical
tenosis with IABP, and IABP mediated significant flow
nhancement after amelioration of severe coronary obstruc-
ions in patients after successful coronary angioplasty (3).
owever, this method is applicable only in the cardiac
atheterization laboratory, and the advancement of the
oppler guide wire beyond severe stenosis could impede
oronary blood flow and adversely affect distal flow mea-
urement. Several recent studies have reported that coronary
ow velocity (CFV) in the distal part of the left anterior
escending coronary artery (LAD) can be successfully mea-
ured by transthoracic Doppler echocardiography (TTDE),
nd measurements of coronary flow velocity reserve have
een useful for detecting functionally significant LAD
From the *Department of Internal Medicine, Tane General Hospital, Osaka,
apan; †Department of Cardiology, Iizuka Hospital, Fukuoka, Japan; and ‡Depart-
ent of Internal Medicine and Cardiology, Graduate School of Medicine, Osaka City
niversity, Osaka, Japan.
Manuscript received May 7, 2003; revised manuscript received August 6, 2003,cccepted August 26, 2003.tenosis (7–10). This totally noninvasive approach could
lso be useful for the continuous assessment of CFV during
ABP.
We hypothesized that CFV in the distal part of the LAD
ould be increased by IABP even in patients with critical
roximal stenosis. Thus, the purpose of this study was to
valuate 1) noninvasive assessment of coronary hemody-
amics using TTDE during IABP; and 2) whether this
ethod can be utilized to adjust the timing of balloon
ontrol in critically ill patients.
ETHODS
he study group comprised 40 patients who had placement
f an IABP for typical clinical indications. Written in-
ormed consent for the placement of IABP and emergency
oronary angiography was obtained from the patient, or
amily, or both before the study. The protocol was approved
y the hospital’s ethics committee.
Coronary angiography was performed in a routine fashion
ither after or before insertion of the IABP using the
emoral approach with standard Judkins diagnostic cathe-
ers. Coronary angioplasty (balloon angioplasty, stent de-
loyment) or thrombolytic therapy was performed when
linically indicated. After completion of the necessary in-
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nit.
oronary flow velocity recordings. All data were obtained
uring 1:2 IABP in the coronary care unit. The intra-aortic
alloon inflation was begun at the aortic dicrotic notch, and
eflation was set on the R wave with manual inflation and
eflation adjustments. The TTDE was performed with a
ommercially available ultrasound machine (SONOS 5500,
hilips Medical Systems, Andover, Massachusetts) with a
Abbreviations and Acronyms
APDV  time-averaged peak diastolic velocity
APSV  time-averaged peak systolic velocity
BP  blood pressure
CFV  coronary flow velocity
DFVI  diastolic flow velocity integral
IABP  intra-aortic balloon pumping
LAD  left anterior descending coronary artery
MI  myocardial infarction
QCA  quantitative coronary angiography
SFVI  systolic flow velocity integral
TIMI  Thrombolysis In Myocardial Infarction
TTDE  transthoracic Doppler echocardiography
igure 1. Coronary flow velocity and pressure recordings demonstrating th
ow velocity during 1:2 balloon pumping in a patient with congestive hear
oronary flow velocity (CFV) is with augmented beat, and second and four
umping. Right panel shows aortic pressure. The diastolic pressure befor
abeled S2. (B) Coronary flow velocity and aortic pressure in a patient with
nd third CFV is with augmented beat, and second and fourth CFV is with nonroadband high-frequency (5 to 12 MHz) transducer (S12).
olor Doppler detection of LAD flow was obtained as
reviously described (11,12). Briefly, the left ventricle was
maged in the low parasternal long axis cross section, and
hen the ultrasound beam was inclined laterally. Next,
oronary blood flow in the distal portion of the LAD was
dentified as a color-filled tubular structure in the anterior
nterventricular sulcus under the guidance of Doppler color
ow mapping. The long-axis sections were carefully ad-
usted to minimize the angle between the Doppler beam and
he LAD flow. With a sample volume positioned on the
olor signal in the LAD in diastole, pulsed Doppler signal
racings of flow velocity in the LAD were recorded. Angle
orrection was performed if the angle between ultrasound
eam and coronary flow direction was 20°. The aortic
lood pressure (BP) was simultaneously measured for the
umen of the intra-aortic balloon pump through fluid-filled
ubing using standard pressure transducers.
oronary flow velocity measurements. Phasic coronary
ow velocity signals were recorded at 50- and 100-mm/s
peed, and measurements were made off-line by use of the
uilt-in calculation package of the ultrasound unit (Fig. 1).
cts of intra-aortic balloon pumping. (A) Left panel shows phasic coronary
re and high-risk coronary angioplasty (two-vessel disease). First and third
V is with non-augmented beat. Diastolic CFV is augmented with balloon
balloon pumping is shown at D1. The augmented diastolic pressure was
t anterior MI and left main coronary stenosis plus two-vessel disease. Firste effe
t failu
th CF
e the
recen-augmented beat. Again, diastolic CFV is enhanced with augmented beat.
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Enhanced Coronary Flow Velocity February 4, 2004:368–76he diastolic flow velocity integral (DFVI) was obtained by
lanimetry of the area under the diastolic velocity signal.
he time-averaged peak diastolic flow velocity (APDV) was
etermined from the traced area of the diastolic flow
elocity signal. Deceleration time of diastolic flow velocity
as also measured. At least three augmented and three
on-augmented beats with adequate quality of coronary
ow velocity envelope were measured and averaged in each
etting. In addition to the absolute values, coronary flow
elocity variables were also reported as a percent of non-
ugmented beat value calculated as [(CFV variables aug-
ented  CFV variables non-augmented)/CFV variables
on-augmented]  100. In patients who could be recorded,
dequate systolic CFV envelope, systolic flow velocity inte-
ral (SFVI), and time-averaged peak systolic flow velocity
APSV) were also measured with non-augmented beat and
ith augmented beat.
ptimal timing of balloon control. The effect of balloon
iming on CFV was examined in 13 patients with coronary
rtery disease (CAD). The optimal timing of balloon
nflation was adjusted so that diastolic flow augmentation
oincided with the upstroke of diastolic acceleration flow
elocity. The optimal timing of balloon deflation was
djusted on the R wave of the electrocardiogram (ECG).
fter obtaining CFV with optimal timing of balloon con-
rol, the inflation timing was delayed in 11 patients, and the
eflation timing was moved to a point earlier than the R
ave in seven patients under the continuous recording of
FV.
ressure measurements. Aortic pressure was recorded at
5- and 50-mm/s paper speed. During IABP, the first
owest arterial pressure after the R wave was defined as
on-augmented diastolic pressure (D1) (Fig. 1). The aug-
ented diastolic pressure was labeled S2. The percent
iastolic pressure augmentation was calculated as [(S2 
1)/D1]  100 as previously reported (2,3).
nalysis of coronary angiography. Percent diameter ste-
osis in the LAD and left main coronary artery was
uantitatively analyzed by Philips quantitative coronary
ngiography (QCA) DCI-ACA system or the Toshiba
CA system. Contrast flow through in the LAD was
raded by standard Thrombolysis In Myocardial Infarction
TIMI) flow scale of 0 to 3 from the final coronary
ngiogram (13). Patients were classified according to the
resence and severity of proximal LAD or left main coro-
ary artery stenosis: severe stenosis (90%); intermediate
tenosis (50% to 90%); and no significant stenosis (50%).
bserver variability. Interobserver measurement variabil-
ty was determined by independent measurement on the
ame CFV recording, and by measurement on the indepen-
ent CFV recording in eight randomly selected patients.
ntraobserver variability was determined by having one
bserver remeasure the spectral envelopes in eight patients
ne month apart. Interobserver and intraobserver variabili-
ies were calculated as the SD of the differences between two ieasurements and expressed as a percent of the average
alue.
tatistical analysis. Data are expressed as mean  SD.
ach patient served as his or her own control by using the
on-augmented data as the baseline value. The difference of
FV and pressure data between non-augmented beats and
ugmented beats was evaluated by the paired Student t test.
omparisons of continuous variables among three groups
ere made by analysis of variance (ANOVA). Linear
egression analysis was applied to estimate the relation
etween pressure data and percent diastolic CFV changes.
tatistical differences were considered significant at a value
f p  0.05.
ESULTS
tudy patients. Twenty-six patients had acute MIs, in-
luding 17 anterior, 5 inferior, and 4 lateral infarctions
Table 1). Three patients required IABP for high-risk
oronary angioplasty, and four patients had unstable angina
ith multivessel disease. One patient had intractable ven-
ricular fibrillations after recent MI. Six other patients had
ardiogenic shock, due to acute myocarditis in two, dilated
ardiomyopathy in two, and ischemic cardiomyopathy in
wo patients, respectively. Coronary artery disease was
enerally extensive, and eight patients had significant left
ain coronary stenosis. Final coronary angiography showed
evere proximal LAD or left main stenosis (90%) in seven
atients, intermediate stenosis (50% to 90%) in 11, and no
ignificant stenosis (50%) in 22 patients, respectively.
even patients had received emergency or elective coronary
ypass surgery after the coronary angiography. Four patients
ied of intractable congestive heart failure and hypotension.
In 17 patients with acute anterior infarction, percutane-
us coronary intervention had been performed in 14 pa-
ients (primary coronary angioplasty in 13 and thrombolytic
herapy in 1), and the other three patients did not receive
oronary intervention owing to significant left main coro-
ary stenosis. Final angiography showed TIMI-2 LAD flow
n nine patients and TIMI-3 LAD flow in eight patients.
ystemic hemodynamics. All patients had sinus rhythm
ith a mean heart rate of 87  19 beats/min (range 58 to
24 beats/min) during acquisition of data. Seven patients
ad baseline systolic BP 90 mm Hg. Intra-aortic balloon
umping decreased systolic BP from 105 19 mm Hg with
on-augmented beat to 95  19 mm Hg with augmented
eat (p  0.001). Diastolic BP (61  13 mm Hg) was
ugmented to 118  18 mm Hg (p  0.001), an average
ncrease of 105  70% (range 38% to 440%).
oronary flow velocity. Adequate quality of diastolic cor-
nary flow velocity envelope was obtained in all patients
Table 2). The mean value of diastolic deceleration time was
34  520 ms (range 69 to 2,430 ms). The APDV with
on-augmented beat was 19.2  10.5 cm/s, and IABP
ignificantly increased APDV to 30.0  15.9 cm/s (%
ncrease: 61  38%, p  0.001). The DFVI during balloon
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on-augmented beat (from 7.7  4.4 cm to 12.1  7.5 cm,
 0.001). Although there was no significant correlation
etween baseline systolic BP and percent increase in APDV
r  0.11, p  NS) or percent increase in DFVI (r  0.12,
 NS), significant correlation was noted between percent
iastolic pressure augmentation and percent increase in
PDV (r  0.69, p  0.001); and that in DFVI (r  0.62,
 0.001). Adequate quality of systolic coronary flow
elocity envelope was obtained in 26 of 40 patients. There
as no significant difference of APSV (3.7  11.7 cm/s vs.
.0 11.9 cm/s) and SFVI (1.4 2.1 cm vs. 1.3 2.2 cm)
able 1. Clinical and Angiographic Data
atient No. Age/Gender Diagnosis
1 67/M Myocarditis, cardiogenic shock
2 84/M AMI (anterior)
3 47/M AMI (anterior)
4 80/M AMI (anterior), cardiogenic shock
5 52/M AMI (anterior)
6 82/M AMI (lateral), cardiogenic shock
7 22/M AMI (anterior)
8 88/F RMI (anterior), high-risk PTCA
9 58/M AMI (anterior)
10 77/M AMI (anterior)
11 77/F UAP
12 62/M AMI (anterior)
13 56/M AMI (anterior), cardiogenic shock
14 74/M AMI (anterior)
15 68/F Myocarditis, cardiogenic shock
16 77/M AMI (anterior)
17 77/F AMI (lateral), cardiogenic shock
18 64/M AMI (anterior)
19 40/M AMI (anterior)
20 68/F AMI (anterior)
21 46/M ICM, cardiogenic shock
22 67/F AMI (anterior)
23 66/M DCM, cardiogenic shock
24 55/M AMI (lateral)
25 72/M AMI (inferior)
26 75/F AMI (lateral)
27 68/M AMI (inferior)
28 80/M ICM, high-risk PTCA
29 74/F AMI (inferior), cardiogenic shock
30 60/M UAP
31 74/F UAP
32 81/M AMI (inferior), no reflow after PCI
33 50/F DCM, cardiogenic shock
34 75/M OMI (anterior), UAP
35 69/M AMI (anterior)
36 71/M ICM, cardiogenic shock
37 73/M OMI (lateral), high risk PTCA
38 57/M AMI (inferior), Vf, shock
39 75/F RMI (anterior), Vf, shock
40 63/M AMI (anterior)
Good intracoronary collateral (septal to septal). #  Number of coronary artery seg
AMI  acute myocardial infarction; CAG  coronary angiography; DCM  dila
escending coronary artery; LMCA  left main coronary artery; LMTD  left ma
oronary intervention; POBA  balloon angioplasty; PTCA  coronary angiopl
hrombolysis In Myocardial Infarction flow scale; UAP  unstable angina, Vf  vetween non-augmented beat and augmented beat. tThe effect of proximal coronary stenosis on diastolic CFV
ugmentation during IABP is shown in Figure 2. There was
o significant difference of percent increase in diastolic CFV
mong three groups (p  NS, ANOVA). The same results
ere obtained even if we excluded four patients with normal
oronary arteries.
In 17 patients with acute anterior MI, rapid deceleration
f diastolic flow velocity (diastolic deceleration time 600
s) and early systolic retrograde flow, which were suggestive
f the presence of no-reflow phenomenon (13–16), was
bserved in 12 and 9 patients, respectively. Intra-aortic
alloon pumping increased APDV from 18.8  11.4 cm/s
itial CAG PCI
Final CAG
TIMILAD LMCA
rmal No 0 0 3
D PTCA (stent, #6,7) 0 0 2
D PTCA (stent, #6) 0 0 2
D PTCA (stent, #6) 0 0 2
D PTCA (POBA, #6) 0 0 2
D, LMTD PTCA (stent, #5,11) 100 0 0
D, LMTD PTCR 50 50 2
D PTCA (unsuccessful) 100 0 3*
D PTCA (stent, #6) 10 0 3
D, LMTD No 70 70 3
TD No 15 70 3
D PTCA (stent, #6) 10 0 2
D PTCA (stent, #7) 0 0 2
D PTCA (stent, #6) 15 0 2
rmal No 0 0 3
D PTCA (stent, #6) 0 0 3
D PTCA (stent, #11) 75 0 3
D, LMTD No 99 70 3
D PTCA (stent, #6) 0 0 3
D, LMTD No 70 70 3
D No 99 0 2
D PTCA (stent, #7) 0 0 2
rmal No 0 0 3
D PTCA (stent, #11) 99 0 2
D PTCA (stent, #2) 100 0 0
D PTCA (stent, #11) 90 0 3
D PTCA (stent, #2) 0 0 3
D PTCA (stent, #1,7,11) 0 0 3
D PTCA (stent, #1) 70 0 3
D PTCA (stent, #6) 0 0 3
D No 90 0 3
D PTCA (stent, #3) 0 0 3
rmal No 0 0 3
D PTCA (stent, #1) 100 0 0
D PTCA (stent, #7) 20 0 3
D, LMTD No 50 50 3
D PTCA (stent, #3,4) 70 0 3
D PTCA (stent, #2) 0 0 3
D, LMTD PTCA (stent, #5) 90 20 3
D PTCA (stent, #7) 0 0 3
by American Heart Association classification.
rdiomyopathy; F  female; ICM  ischemic cardiomyopathy; LAD  left anterior
onary disease; M  male; OMI  old myocardial infarction; PCI  percutaneous
TCR  coronary thrombolysis; RMI  recent myocardial infarction; TIMI 
lar fibrillation; VD  vessel disease.In
No
1V
1V
1V
2V
2V
1V
3V
1V
3V
LM
1V
1V
1V
No
1V
2V
3V
1V
2V
3V
3V
No
3V
3V
3V
1V
3V
3V
2V
3V
1V
No
3V
1V
1V
2V
2V
2V
2V
ments
ted ca
in cor
asty; P
entricuo 26.9  14.9 cm/s (p  0.001) and DFVI from 6.3  4.4
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Enhanced Coronary Flow Velocity February 4, 2004:368–76m to 9.4 6.7 cm (p 0.005) in 12 patients with diastolic
eceleration time 600 ms, and from 20.4  13.3 cm/s to
7.9  15.9 cm/s (p  0.001) and 6.5  5.5 cm to 9.3 
.0 cm (p  0.05), respectively, in 9 patients with early
ystolic retrograde flow. There was no significant difference
f percent increase in APDV (52  29% vs. 60  15%) and
FVI (55  33% vs. 65  21%) between patients with
apid diastolic deceleration time and those without. No
ifference of percent increase in APDV (49 32% vs. 61
4%) and that in DFVI (52 38% vs. 64 17%) was noted
etween patients with systolic retrograde flow and those
Table 2. Coronary Flow Velocity Data
Patient SRF DcT
APD
Base I
1 Yes 1,083 12.3
2 Yes 80 7.3
3 Yes 96 22.4
4 Yes 71 16.2
5 No 360 6.4
6 No 152 18.8
7 Yes 90 34.8
8 No 1,250 15.0
9 No 152 31.3
10 No 917 20.0
11 No 2,430 16.6
12 Yes 228 6.1
13 Yes 113 11.8
14 Yes 210 9.5
15 No 778 22.8
16 Yes 69 38.9
17 No 1,000 16.6
18 No 1,194 7.8
19 No 930 36.7
20 No 750 17.8
21 No 1,597 12.0
22 No 305 17.4
23 No 1,458 32.7
24 No 718 13.3
25 No 708 5.9
26 No 985 16.0
27 No 760 10.2
28 No 855 26.5
29 No 620 11.0
30 No 1,107 13.7
31 No 1,577 17.0
32 No 620 21.9
33 No 674 38.0
34 No 703 7.3
35 No 815 4.5
36 No 432 41.0
37 No 660 31.6
38 No 1,350 20.7
39 No 970 35.4
40 No 430 23.3
Mean 734 19.2
SD 520 10.5
APDV time-averaged peak diastolic velocity; Base nona
velocity; DFVI  diastolic flow velocity integral; IABP 
increase.ithout. There was no significant difference of APSV (9.8 (.7 cm/s vs. 10.7  10.0 cm/s) and SFVI (1.2  1.0 cm
s. 1.4  1.0 cm) between non-augmented beat and aug-
ented beat in nine patients with systolic retrograde flow.
ffect of balloon timing on CFV. Optimal balloon infla-
ion was achieved to adjust diastolic flow augmentation to
oincide with upstroke of diastolic acceleration flow (Fig.
B, arrow). Delayed balloon inflation significantly decreased
PDV (42.7  14.8 cm/s vs. 37.9  13.4 cm/s, p  0.001)
nd DFVI (16.2  6.1 cm vs. 13.8  5.0 cm, p  0.001)
Fig. 4). Although D1 did not change (64.4  9.1 mm Hg
s. 64.8  10.6 mm Hg), S2 also significantly decreased
m/s) DFVI (cm)
% Base IABP %
26.8 4.4 6.4 44.8
108.7 2.4 4.4 85.5
28.8 4.2 4.6 9.2
51.9 3.1 5.7 82.8
52.9 4.3 6.3 49.2
30.3 5.6 7.7 36.8
10.5 10.6 12.5 17.9
228.0 9.6 28.1 192.1
73.2 16.4 26.6 62.2
65.0 10.3 16.2 57.3
37.4 11.9 16.0 34.5
94.2 1.9 4.2 124.3
38.1 3.9 4.8 23.6
32.3 3.9 5.1 31.2
60.5 7.4 11.2 50.9
28.8 10.1 14.5 43.6
48.8 8.3 12.1 46.2
66.7 3.7 6.8 83.8
43.9 18.5 28.2 52.4
46.1 6.8 9.5 40.5
23.3 4.2 4.4 7.0
63.2 5.9 9.6 62.6
45.3 14.5 22.0 51.7
37.6 5.1 7.2 40.8
63.0 2.5 3.6 43.8
67.5 6.3 9.5 51.7
102.9 3.6 5.8 59.9
59.3 13.0 17.7 36.2
107.2 4.3 9.4 120.3
62.0 5.1 8.2 59.2
82.4 7.8 13.2 69.2
127.4 9.0 19.2 113.6
31.6 11.3 14.9 31.9
62.7 3.3 5.4 61.1
80.6 2.4 4.6 90.8
30.5 14.8 19.7 32.8
76.7 14.7 27.5 87.7
24.0 8.9 10.6 18.7
94.2 14.0 24.8 77.7
39.5 9.1 14.9 63.6
61.3 7.7 12.1 58.7
38.3 4.4 7.5 35.2
ted beat; DcT deceleration time of diastolic coronary flow
nted beat; SRF  systolic retrograde flow; %  percentV (c
ABP
15.6
15.3
28.9
24.6
9.8
24.5
38.5
49.2
54.2
33.0
22.8
11.8
16.3
12.5
36.6
50.1
24.7
13.0
52.8
26.0
14.8
28.4
47.5
18.3
9.7
26.8
20.7
42.2
23.0
22.2
31.0
49.8
50.0
11.9
8.2
53.5
55.9
25.7
68.7
32.5
30.0
15.9
ugmen
augme122.2 16.6 mm Hg vs. 110.2 14.6 mm Hg, p 0.05).
E
(
D
H
H
m
O
F
p
significant stenosis; black bars  intermediate stenosis; open bars  severe stenosis.
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February 4, 2004:368–76 Enhanced Coronary Flow Velocityarly balloon deflation also significantly decreased APDV
42.1  18.3 cm/s vs. 36.6  16.1 cm/s, p  0.05) and
FVI (17.6  7.5 cm vs. 14.2  5.3 cm, p  0.05).
owever, there was no difference of D1 (64.8  11.6 mm p
ave on electrocardiogram (arrows).g vs. 64.6 12.4 mm Hg, p NS) and S2 (130.2 10.1
m Hg vs. 121.3  8.5 mm Hg, p  0.1).
bserver variabilities. Interobserver variability by inde-igure 2. Effect of balloon pumping on coronary flow velocity among three groups according to the severity of proximal stenosis. APDV  time-averaged
eak diastolic velocity (cm/s); DFVI  diastolic flow velocity integral (cm); IABP%  percent increase intra-aortic balloon pumping. Shaded bars  noendent measurement on the same recording and theigure 3. Adjustment of balloon timing during coronary flow velocity recording. Coronary flow velocity during 1:2 balloon pumping in a patient with
igh-risk percutaneous transluminal coronary angioplasty. Upper panel shows coronary flow velocity and lower panel shows aortic blood pressure. (A)
elayed inflation; there is a notch between diastolic deceleration flow and augmentation flow (arrow). (B) Optimal timing of balloon control; diastolic flow
ugmentation coincides with the upstroke of diastolic acceleration flow velocity (arrow). (C) Early deflation; flow velocity is terminated early before the R-
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Enhanced Coronary Flow Velocity February 4, 2004:368–76ndependent recordings were 4.8% and 7.3%, respectively.
ntraobserver variability for the measurements of CFV
ecordings was 3.0%.
ISCUSSION
his study demonstrates that the measurement of diastolic
FV in the distal part of the LAD by TTDE during IABP
as highly feasible and that diastolic CFV was increased
ignificantly with augmented diastolic pressure during
ABP, even in patients with critical proximal stenosis.
iastolic CFV in the distal LAD was also augmented by
ABP in patients with reperfused anterior MI and no-reflow
henomenon. These results directly support the potential
or augmenting myocardial perfusion during balloon pump-
ng. We also demonstrated that optimal balloon timing on
oronary flow augmentation could be adjusted under the
uidance of CFV recording by TTDE. Thus, TTDE is
seful for non-invasive assessment of coronary hemodynam-
cs during IABP.
revious studies. Controversy exists regarding the ability
f IABP to increase coronary blood flow in patients who are
ritically ill or who have significant atherosclerotic coronary
tenosis (1–4,6). Although previous studies demonstrated
ignificantly augmented CFV in the proximal LAD by
ransesophageal echocardiography (6) or augmented CFV
n the proximal coronary arteries by Doppler catheters (2),
hose studies did not address distal flow response in the
resence of obstructive coronary narrowings. Subsequently,
ern et al. (3) used Doppler-tipped angioplasty guide wire
or measuring CFV distal to the stenosis during IABP and
Figure 4. Individual value of coronary flow velocity during adjusemonstrated a limited distal flow velocity and a failure to encrease flow beyond the most critical coronary stenosis.
fter relief of vessel occlusion or severe coronary stenosis by
ngioplasty, a 25% augmentation of distal mean CFV and a
5% increase in distal diastolic velocity integral was ob-
erved by IABP. However, the advancement of Doppler
uide wire itself across the severe stenosis could impede
istal coronary blood flow and adversely affect flow
easurements.
urrent study. To our best knowledge, this is the first
tudy to examine the effect of IABP on CFV in the distal
AD by TTDE. Adequate quality of diastolic CFV enve-
ope in the distal LAD was obtained in all patients, and a
0% augmentation of distal CFV by balloon pumping was
bserved. In contrast to the results of previous studies.
ABP produced significant distal flow enhancement even in
atients with critical proximal LAD stenosis.
Diastolic aortic pressure is a well-known determinant of
oronary flow; thus, an increase in the diastolic pressure
nduced by IABP will have a significant impact on coronary
ow augmentation (6). The significant correlation between
ercent diastolic pressure augmentation and percent in-
rease in diastolic CFV in this study was in agreement with
revious studies (2,6). Although we did not measure coro-
ary pressure at the site of CFV recording, these findings
uggest that autoregulation of CFV was lost or out of range
n the critically ill, and the change in the CFV depends on
he degree of distal perfusion pressure.
Patients who experience no-reflow phenomenon after MI
ave an increased risk of poor left ventricular function and
rognosis (17–19). The CFV pattern of no-reflow phenom-
of the timing of balloon control. Abbreviations as in Figure 2.tmentnon in patients with reperfused acute MI is characterized
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February 4, 2004:368–76 Enhanced Coronary Flow Velocityy the appearance of systolic retrograde flow and rapid
eceleration slope of diastolic flow by use of a Doppler guide
ire (13–15). In patients with reperfused acute anterior MI,
e demonstrated that the degree of diastolic CFV enhance-
ent by IABP was comparable between patients with
ystolic retrograde flow/rapid deceleration slope and those
ithout. There was no significant difference of systolic flow
elocity between the non-augmented beat and the aug-
ented beat in patients with systolic retrograde flow. These
esults suggest that in addition to pharmacologic interven-
ions (20,21). IABP is an effective therapeutic strategy to
nhance CFV in no-reflow phenomenon.
This study also showed that the degree of the increase in
FV by IABP depends on the timing of balloon inflation
nd deflation, and TTDE allows adjusting the optimal
iming of balloon control for maximal CFV enhancement.
his is another advantage of noninvasive monitoring of
FV during balloon pumping.
tudy limitations. Flow velocity measurements do not
rovide an absolute value but are linearly related to changes
n absolute flow when vessel area remains constant. Al-
hough we did not measure coronary vessel diameter,
nchanged diameter during balloon pumping was reported
n a previous study (3).
Coronary flow velocity measurements were not per-
ormed before the interventional therapy but were per-
ormed after the patients were admitted to the coronary care
nit. Thus, we cannot guarantee whether the same results
ould be obtained before coronary intervention in the
ardiac catheterization laboratory.
It was only in two-thirds of the study patients that an
dequate quality systolic flow velocity envelope could be
ecorded, because of the movement of coronary vessels
uring cardiac cycle and wall motion artifact. However,
iastolic flow is dominant in this part of the epicardial
oronary artery. The finding that no significant change in
ystolic flow velocity between non-augmented beat and
ugmented beat was observed in this study, especially in
atients with systolic retrograde flow, suggests that systolic
ow velocity has only a small impact on coronary flow
ugmentation during IABP.
onclusions. Transthoracic Doppler echocardiography
an be used in monitoring CFV augmentation during
ABP. In contrast to previous invasive studies, IABP
roduced significant distal flow enhancement even in pa-
ients with critical proximal stenosis. This totally noninva-
ive approach may help to optimize the benefits of IABP for
oronary flow augmentation.
eprint requests and correspondence: Dr. Masaaki Takeuchi,
epartment of Internal Medicine, Tane General Hospital, 1-2-31
akaigawa, Nishi-ku, Osaka, 550-0024 Japan. E-mail: masaaki_
akeuchi@hotmail.com.EFERENCES
1. Katz ES, Tunick PA, Kronzon I. Observations of coronary flow
augmentation and balloon function during intraaortic balloon coun-
terpulsation using transesophageal echocardiography. Am J Cardiol
1992;69:1635–9.
2. Kern MJ, Aguirre FV, Tatineni S, et al. Enhanced coronary blood flow
velocity during intraaortic balloon counterpulsation in critically ill
patients. J Am Coll Cardiol 1993;21:359–68.
3. Kern MJ, Aguirre F, Bach R, Donohue T, Siegel R, Segal J.
Augmentation of coronary blood flow by intra-aortic balloon
pumping in patients after coronary angioplasty. Circulation 1993;
87:500 –11.
4. Port SC, Patel S, Schmidt DH. Effects of intraaortic balloon coun-
terpulsation on myocardial blood flow in patients with severe coronary
artery disease. J Am Coll Cardiol 1984;3:1367–74.
5. Ryan EW, Foster E. Images in cardiovascular medicine. Augmenta-
tion of coronary blood flow with intra-aortic balloon pump counter-
pulsation. Circulation 2000;102:364–5.
6. Zehetgruber M, Mundigler G, Christ G, et al. Relation of hemody-
namic variables to augmentation of left anterior descending coronary
flow by intraaortic balloon pulsation in coronary artery disease. Am J
Cardiol 1997;80:951–5.
7. Caiati C, Montaldo C, Zedda N, Bina A, Iliceto S. New noninvasive
method for coronary flow reserve assessment: contrast-enhanced
transthoracic second harmonic echo Doppler. Circulation 1999;99:
771–8.
8. Caiati C, Zedda N, Montaldo C, Montisci R, Iliceto S. Contrast-
enhanced transthoracic second harmonic echo Doppler with adeno-
sine: a noninvasive, rapid and effective method for coronary flow
reserve assessment. J Am Coll Cardiol 1999;34:122–30.
9. Daimon M, Watanabe H, Yamagishi H, et al. Physiologic assessment
of coronary artery stenosis by coronary flow reserve measurements with
transthoracic Doppler echocardiography: comparison with exercise
thallium-201 single piston emission computed tomography. J Am Coll
Cardiol 2001;37:1310–5.
0. Hozumi T, Yoshida K, Ogata Y, et al. Noninvasive assessment of
significant left anterior descending coronary artery stenosis by coronary
flow velocity reserve with transthoracic color Doppler echocardiogra-
phy. Circulation 1998;97:1557–62.
1. Takeuchi M, Miyazaki C, Yoshitani H, Otani S, Sakamoto K,
Yoshikawa J. Assessment of coronary flow velocity with transthoracic
Doppler echocardiography during dobutamine stress echocardiogra-
phy. J Am Coll Cardiol 2001;38:117–23.
2. Takeuchi M, Yoshitani H, Miyazaki C, Otani S, Sakamoto K,
Yoshikawa J. Relation between changes in coronary flow velocity
and in wall motion for assessing contractile reserve during dobut-
amine stress echocardiography. J Am Soc Echocardiogr 2002;15:
1290 –6.
3. Kawamoto T, Yoshida K, Akasaka T, et al. Can coronary blood flow
velocity pattern after primary percutaneous transluminal coronary
angioplasty [correction of angiography] predict recovery of regional left
ventricular function in patients with acute myocardial infarction?
Circulation 1999;100:339–45.
4. Iwakura K, Ito H, Takiuchi S, et al. Alternation in the coronary blood
flow velocity pattern in patients with no-reflow and reperfused acute
myocardial infarction. Circulation 1996;94:1269–75.
5. Iwakura K, Ito H, Nishikawa N, et al. Early temporal changes in
coronary flow velocity patterns in patients with acute myocardial
infarction demonstrating the “no-reflow” phenomenon. Am J Cardiol
1999;84:415–9.
6. Shintani Y, Ito H, Iwakura K, et al. Prediction of wall motion recovery
from the left anterior descending coronary artery velocity pattern
recorded by transthoracic Doppler echocardiography in patients with
anterior wall myocardial infarction retrospective and prospective stud-
ies. Jpn Circ J 2001;65:717–22.
7. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion
immediately after successful thrombolysis. A predictor of poor recovery
of left ventricular function in anterior myocardial infarction. Circula-
tion 1992;85:1699–705.
8. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the ‘no
reflow’ phenomenon. A predictor of complications and left ventricular
12
2
376 Takeuchi et al. JACC Vol. 43, No. 3, 2004
Enhanced Coronary Flow Velocity February 4, 2004:368–76remodeling in reperfused anterior wall myocardial infarction. Circula-
tion 1996;93:223–8.
9. Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow
phenomenon as a predictor of adverse long-term outcome in
patients treated with percutaneous transluminal coronary angio-
plasty for first acute myocardial infarction. J Am Coll Cardiol
2000;36:1202–9.0. Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can
preserve microvascular integrity and myocardial viability in patients
with reperfused anterior wall myocardial infarction. J Am Coll Cardiol
1999;33:654–60.
1. Taniyama Y, Ito H, Iwakura K, et al. Beneficial effect of intracoronary
verapamil on microvascular and myocardial salvage in patients with
acute myocardial infarction. J Am Coll Cardiol 1997;30:1193–9.
